Treatment Options for ATTR-CM
HealthTransthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and life-threatening condition characterized by the buildup of abnormal protein deposits called amyloid in the heart tissue. This article will explore the various treatment approaches for ATTR-CM, including FDA-approved medications, off-label therapies, emerging treatments and lifestyle modifications to help manage symptoms and improve quality of life. Tafamidis is the first and only FDA-approved medication specifically for treating ATTR-CM. It works as a transthyretin stabilizer, binding to TTR protein and preventing its dissociation into...